Paul J Lytle insider trades

Open-market stock purchases and sales by Paul J Lytle, Chief Financial Officer at Actuate Therapeutics, Inc, from SEC Form 4 filings since Feb 1, 2010.

Recent trades

DateStockTradeValue
Apr 1, 2026ACTU Actuate Therapeutics, IncBought (not open market)—

Companies traded

  • ACTU Actuate Therapeutics, Inc: other filings, last Apr 1, 2026
  • CPMV Mosaic ImmunoEngineering Inc: other filings, last Jan 29, 2021
  • PTSCD Mosaic ImmunoEngineering Inc: other filings, last Dec 16, 2020
  • PPHM Peregrine Pharmaceuticals Inc: 2 buys, last Apr 28, 2017

Get free alerts when Paul J Lytle files a new trade →